A detailed history of Nations Financial Group Inc, transactions in United Therapeutics Corp stock. As of the latest transaction made, Nations Financial Group Inc, holds 2,904 shares of UTHR stock, worth $1.06 Million. This represents 0.08% of its overall portfolio holdings.

Number of Shares
2,904
Previous 2,768 4.91%
Holding current value
$1.06 Million
Previous $881,000 18.05%
% of portfolio
0.08%
Previous 0.07%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 04, 2024

BUY
$311.04 - $363.55 $42,301 - $49,442
136 Added 4.91%
2,904 $1.04 Million
Q2 2024

Jul 29, 2024

BUY
$228.26 - $319.04 $303,357 - $424,004
1,329 Added 92.36%
2,768 $881,000
Q1 2024

Apr 23, 2024

BUY
$210.76 - $249.51 $83,882 - $99,304
398 Added 38.23%
1,439 $330,000
Q4 2023

Feb 09, 2024

BUY
$214.88 - $256.94 $223,690 - $267,474
1,041 New
1,041 $228,000

Others Institutions Holding UTHR

About UNITED THERAPEUTICS Corp


  • Ticker UTHR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 45,516,300
  • Market Cap $16.6B
  • Description
  • United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...
More about UTHR
Track This Portfolio

Track Nations Financial Group Inc, Portfolio

Follow Nations Financial Group Inc, and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nations Financial Group Inc, , based on Form 13F filings with the SEC.

News

Stay updated on Nations Financial Group Inc, with notifications on news.